Company intelligence / Profile preview

Canova

Curitiba, Paraná, Brazilcanovadobrasil.com.br ↗
Ownership
Private
Development stage
Other
01

Overview

Canova do Brasil (Laboratorio Canova do Brasil Ltda) is a Brazilian pharmaceutical company based in Curitiba, Paraná, specializing in the research, development, and manufacturing of immunomodulatory medicines. The company's flagship product, Canova (also known as Canova Method or Canovex), is a complex homeopathic formulation composed of natural plant, animal, and mineral extracts, including Aconitum napellus, Bryonia alba, Thuja occidentalis, Lachesis muta venom, and Arsenicum album. Canova acts as a biological response modifier that stimulates the immune system by activating macrophages, promoting lymphocyte proliferation, and regulating cytokine production (such as decreasing TNF-alpha). It is primarily used as an adjunctive therapy to support patients with compromised immune systems, such as those undergoing chemotherapy for cancer, or individuals living with HIV/AIDS and other infectious diseases.

Therapeutic areas
OncologyInfectious DiseasesImmunology
Modalities
Homeopathic formulationPlant extractAnimal extractMineral extract
Industry
Pharma
02

Drug pipeline

1 asset

Canova Drops

Preclinical

Beyond the preview

Go deeper on Canova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Canova.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call